Trading Options with an Edge
Select Page

MNKD

Search by
TICKER SYMBOL

Mannkind Corp

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing

4.07

-0.08

(-1.928%)

Volume:

3,541,613

52 week range:

2.49 - 5.44

Market Cap:

1.028B

Company Description:

MannKind Corporation focuses on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases. MannKind is currently commercializing Afrezza® (insulin human) Inhalation Powder, its first FDA-approved product and the only inhaled ultra rapid-acting mealtime insulin in the United States, where it is available by prescription from pharmacies nationwide. MannKind is headquartered in Westlake Village, California, and has a state-of-the art manufacturing facility in Danbury, Connecticut.